Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 335,659 | 26,678 | 129,160 | 0 | 0 |
| Gross Profit | 335,659 | 26,678 | 129,160 | N/A | N/A |
| Operating Expenses | 272,941 | 239,862 | 175,532 | 90,140 | 87,433 |
| Operating Income | 62,718 | -213,184 | -46,372 | -90,140 | -87,433 |
| Other Income | 9,241 | 15,219 | 10,132 | 1,955 | 781 |
| Pre-tax Income | 71,959 | -197,965 | -36,240 | -88,185 | -86,652 |
| Income Tax | 823 | -351 | N/A | N/A | N/A |
| Net Income Continuous | 71,136 | -197,614 | -36,240 | -88,185 | -86,652 |
| Net Income | $71,136 | $-197,614 | $-36,240 | $-88,185 | $-86,652 |
| EPS Basic Total Ops | 0.65 | -2.07 | -0.39 | -5.89 | -13.49 |
| EPS Basic Continuous Ops | 0.65 | -2.07 | -0.39 | -5.89 | -13.49 |
| EPS Diluted Total Ops | 0.63 | -2.07 | -0.39 | -5.89 | -13.49 |
| EPS Diluted Continuous Ops | 0.63 | -2.07 | -0.39 | -5.89 | -13.49 |
| EPS Diluted Before Non-Recurring Items | 0.63 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $71,304 | $-210,212 | $-41,662 | $-86,305 | $-85,660 |